Literature DB >> 29094335

Association of malocclusion, self-reported bruxism and chewing-side preference with oral health-related quality of life in patients with temporomandibular joint osteoarthritis.

Naichuan Su1,2,3, Yan Liu4, Xianrui Yang1,5, Jiefei Shen1,2, Hang Wang1,2.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the association of oral health-related quality of life (OHRQoL) with malocclusion and self-reported bruxism and chewing-side preference (CSP) in patients with temporomandibular joint osteoarthritis (TMJ-OA).
METHODS: This study involved 511 patients diagnosed with TMJ-OA. Each participant completed the Chinese version of the 14-item Oral Health Impact Profile (OHIP-C14) questionnaire and received a clinical examination concerning malocclusion (posterior crossbite, overbite, overjet and anterior open bite). Also patients' self-reported awake bruxism (AB), sleep bruxism (SB) and CSP based on the Oral Behavior Checklist (OBC) were recorded. The associations of OHIP-C14 with malocclusion and self-reported bruxism and CSP were assessed using multiple linear regression analysis.
RESULTS: Posterior crossbite, overbite, overjet and anterior open bite were not significantly associated with either the total OHIP-C14 score or the scores of each domain of OHIP-C14. AB was significantly associated with both the total OHIP-C14 score and the scores of each domain with the largest standardised coefficients. CSP was significantly associated with both the total OHIP-C14 score and the scores of the psychological and social domains. SB was significantly associated with the scores of both the function limitation and psychological disability domains.
CONCLUSIONS: Malocclusion is not significantly associated with OHRQoL in patients with TMJ-OA. Self-reported AB is highly associated with OHRQoL in patients with TMJ-OA, while self-reported SB and CSP are both moderately associated with OHRQoL in patients with TMJ-OA.
© 2017 FDI World Dental Federation.

Entities:  

Keywords:  Temporomandibular joint disorders; bruxism; malocclusion; osteoarthritis; quality of life

Mesh:

Year:  2017        PMID: 29094335      PMCID: PMC9378935          DOI: 10.1111/idj.12344

Source DB:  PubMed          Journal:  Int Dent J        ISSN: 0020-6539            Impact factor:   2.607


  43 in total

1.  Diagnosis and treatment of temporomandibular disorders.

Authors:  Harry Dym; Howard Israel
Journal:  Dent Clin North Am       Date:  2012-01

2.  [Validation of a Chinese version of the oral health impact profile-14].

Authors:  Wei-ni Xin; Jun-qi Ling
Journal:  Zhonghua Kou Qiang Yi Xue Za Zhi       Date:  2006-04

3.  Self-Reported bruxism and associated factors in Israeli adolescents.

Authors:  A Emodi Perlman; F Lobbezoo; A Zar; P Friedman Rubin; M K A van Selms; E Winocur
Journal:  J Oral Rehabil       Date:  2016-03-09       Impact factor: 3.837

Review 4.  Assessment of mastication with implications for oral rehabilitation: a review.

Authors:  Andries van der Bilt
Journal:  J Oral Rehabil       Date:  2011-01-17       Impact factor: 3.837

5.  Nonfunctional tooth contact in healthy controls and patients with myogenous facial pain.

Authors:  Cheng-Yi Chen; Sandro Palla; Stefan Erni; Martin Sieber; Luigi M Gallo
Journal:  J Orofac Pain       Date:  2007

6.  Impact of malocclusion and common oral diseases on oral health-related quality of life in young adults.

Authors:  Sung-Hwan Choi; Baek-Il Kim; Jung-Yul Cha; Chung-Ju Hwang
Journal:  Am J Orthod Dentofacial Orthop       Date:  2015-05       Impact factor: 2.650

7.  The classification of orofacial pains.

Authors:  Jeffrey P Okeson
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2008-05       Impact factor: 2.802

8.  Study of the relationship of psychosocial disorders to bruxism in adolescents.

Authors:  E Katayoun; F Sima; V Naser; D Anahita
Journal:  J Indian Soc Pedod Prev Dent       Date:  2008

9.  Parafunctional clenching, pain, and effort in temporomandibular disorders.

Authors:  Alan G Glaros; Eric Burton
Journal:  J Behav Med       Date:  2004-02

Review 10.  Molecular biology of temporomandibular joint disorders: proposed mechanisms of disease.

Authors:  S B Milam; J P Schmitz
Journal:  J Oral Maxillofac Surg       Date:  1995-12       Impact factor: 1.895

View more
  5 in total

1.  Temporomandibular Joint Osteoarthritis: Regenerative Treatment by a Stem Cell Containing Advanced Therapy Medicinal Product (ATMP)-An In Vivo Animal Trial.

Authors:  Robert Köhnke; Marcus Oliver Ahlers; Moritz Alexander Birkelbach; Florian Ewald; Michael Krueger; Imke Fiedler; Björn Busse; Max Heiland; Tobias Vollkommer; Martin Gosau; Ralf Smeets; Rico Rutkowski
Journal:  Int J Mol Sci       Date:  2021-01-05       Impact factor: 5.923

2.  Temporomandibular disorders in patients with polysomnographic diagnosis of sleep bruxism: a case-control study.

Authors:  Andrea Sinclair; Mieszko Wieckiewicz; Dominik Ettlin; Raimundo Junior; Antônio Sérgio Guimarães; Michele Gomes; Miguel Meira E Cruz
Journal:  Sleep Breath       Date:  2021-08-08       Impact factor: 2.816

Review 3.  Temporomandibular Joint Regenerative Medicine.

Authors:  Xavier Van Bellinghen; Ysia Idoux-Gillet; Marion Pugliano; Marion Strub; Fabien Bornert; Francois Clauss; Pascale Schwinté; Laetitia Keller; Nadia Benkirane-Jessel; Sabine Kuchler-Bopp; Jean Christophe Lutz; Florence Fioretti
Journal:  Int J Mol Sci       Date:  2018-02-02       Impact factor: 5.923

4.  Local Injection of Growth Hormone for Temporomandibular Joint Osteoarthritis.

Authors:  Soo Min Ok; Jin Hwa Kim; Ji Su Kim; Eun Gyo Jeong; Yang Mi Park; Hye Mi Jeon; Jun Young Heo; Yong Woo Ahn; Sun Nyoung Yu; Hae Ryoun Park; Kyung Hee Kim; Soon Cheol Ahn; Sung Hee Jeong
Journal:  Yonsei Med J       Date:  2020-04       Impact factor: 2.759

5.  Bruxism, Related Factors and Oral Health-Related Quality of Life Among Vietnamese Medical Students.

Authors:  Nguyen Thi Thu Phuong; Vo Truong Nhu Ngoc; Le My Linh; Nguyen Minh Duc; Nguyen Thu Tra; Le Quynh Anh
Journal:  Int J Environ Res Public Health       Date:  2020-10-12       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.